- $38.15m
- $33.47m
- $18.79m
Nephros Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Nephros Announces Agreement To Sell Pathogen Detection Systems Business
Brief: Nephros Appoints Joe Harris To Its Board Of Directors
Nephros Inc reports results for the quarter ended in June - Earnings Summary
Brief: Nephros Announces Quarterly Results
Nephros Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Nephros Announces Preliminary Results For Quarter Ended June 30, 2022 And Projects Positive Net Cash Flow In 12 Months
Brief: Nephros Receives FDA 510(K) Clearance For Hdf Assist Module
Nephros Inc reports results for the quarter ended in March - Earnings Summary
Brief: Nephros Announces Results For Quarter Ended March 31, 2022
Nephros Inc expected to post a loss of 11 cents a share - Earnings Preview
Nephros Inc reports results for the quarter ended in December - Earnings Summary
Brief: Nephros Announces Q4 And 2021 Financial Results
Nephros Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Nephros Sees FY 2022 Revenue $13 Million To $13.5 Million
Brief: Nephros Sees Q4 Revenue Up 18 Percent
Nephros Inc reports results for the quarter ended in September - Earnings Summary
Brief: Nephros Announces Results For Quarter Ended September 30, 2021
Brief: Nephros Inc Announces Preliminary Results For Third Quarter Of 2021